Structure Toxicity Relationships - How Useful Are They in Predicting Toxicities of New Drugs?
Reference67 articles.
1. Al-Salman, J., Arjomand, H., Kemp, D.G., and Mittal, M., 2000, Hepatocellular injury in a patient receiving rosiglitazone. A case report, Ann. Intern. Med
132:121–124. 2. Alvir, M.J., and Lieberman, J.A., 1994, A reevaluation of the clinical characteristics of clozapine-induced agranulocytosis in light of the United States Experience, J. Clin. Psychopharmacol
14:87–89. 3. Andrade, R.J., Lucena, M.I., Martin-Vivaldi, R., Fernandez, M.C., Nogueras, F., Pelaez, G., Gomez-Outes, A., Garcia-Escaño, M.D., Bellot, U., Hervás, A., Cárdenas, F., Bermudez, F., Romero, M., and Salmerón, J., 1999, Acute liver injury associated with ebrotidine, a new H2-receptor antagonist, J. Hepatology
31:641–646. 4. Andrade, R.J., Lucena, M.I., Fernández, M.C., Suárez, F., Montero, J.L., Fraga, E., and Hidalgo, F., 1999, Fulminant liver failure associated with flutamide therapy for hirsutism, Lancet
353:983. 5. Assal, F., Spahr, L., Hadengue, A., Rubbici-Brandt, L., and Burkhard, P.R., 1998, Tolcapone and fulminant hepatitis, Lancet
352:958.
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|